Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

1.85USD
22 Feb 2018
Change (% chg)

$-0.03 (-1.33%)
Prev Close
$1.88
Open
$1.90
Day's High
$1.90
Day's Low
$1.85
Volume
31,042
Avg. Vol
120,460
52-wk High
$5.75
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
FY 2016 Dec '16 6.43 -0.214
Sep '16 3.37 -0.252
Jun '16 4.53 -0.245
Mar '16 3.03 -0.242
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.90 0.90 0.90 1.50
Quarter Ending Jun-18 1 1.30 1.30 1.30 2.00
Year Ending Dec-18 3 16.73 30.60 8.30 43.40
Earnings (per share)
Quarter Ending Mar-18 1 -0.20 -0.20 -0.20 -0.27
Quarter Ending Jun-18 1 -0.22 -0.22 -0.22 -0.27
Year Ending Dec-18 3 -1.01 -0.85 -1.18 -0.56
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta 3.03 0.90 0.89
Price to Sales (TTM) 14.87 110.72 5.77
Price to Book (MRQ) -- 13.56 5.41
Price to Tangible Book (MRQ) -- 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 39.70 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.32 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -37.00 78.63 5.59
Sales - 5 Yr. Growth Rate 74.52 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.56 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago -79.25 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate 13.00 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.81 1.80 2.18
Current Ratio (MRQ) 4.92 5.30 2.97
LT Debt to Equity (MRQ) -- 22.82 12.22
Total Debt to Equity (MRQ) -- 24.47 16.52
Interest Coverage (TTM) -1.82 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 13.88 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -225.81 -- --
EBITD - 5 Yr. Avg -161.51 -572.68 10.86
Operating Margin (TTM) -238.47 -717.10 4.64
Operating Margin - 5 Yr. Avg. -170.81 -594.00 6.26
Pre-Tax Margin (TTM) -319.40 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -212.89 -597.35 6.60
Net Profit Margin (TTM) -319.19 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -213.88 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 399,205 22,602,121 855,668,157
Net Income/Employee (TTM) -1,274,205 2,968,747 100,655,595
Receivable Turnover (TTM) 4.98 20.14 5.78
Inventory Turnover (TTM) 9.22 2.36 3.35
Asset Turnover (TTM) 0.16 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.83 -1.05 10.98
Return on Assets - 5 Yr. Avg. -34.34 -0.57 12.37
Return on Investment (TTM) -63.23 1.66 14.43
Return on Investment - 5 Yr. Avg. -39.19 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -81.78 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -9.89 -16.21 74.52
EPS (TTM) % -72.93 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 28.74%
# of Holders: 68
Total Shares Held: 14,468,935
3 Mo. Net Change: -2,171,017
# New Positions: 9
# Closed Positions: 15
# Increased Positions: 28
# Reduced Positions: 34
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.